EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Circulating levels of endogenous complement inhibitors correlate inversely with complement consumption in systemic lupus erythematosus

Stef van der Meulen iD, Rory C Monahan iD, Kyra A Gelderman iD, Cees van Kooten iD, Y K Onno Teng iD, Tom W J Huizinga iD, Gerda M Steup-Beekman iD, Leendert A Trouw iD

European Journal of Immunology · 2024-11 · 54 (11)

DOI: 10.1002/eji.202450998 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Immunology, online erschienen am 20.08.2024. Verfasst von Stef van der Meulen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, Leiden University Medical Center, Leiden, the Netherlands. Hauptthemen laut MEDLINE: Lupus Erythematosus, Systemic, Complement C1 Inhibitor Protein, Biomarkers, Complement Factor H. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Systemic lupus erythematosus (SLE) is marked by excessive complement activation, contributing to tissue damage. Complement activation can be detected in many organs including the skin, kidney, and brain. The involvement of the central nervous system is particularly relevant to understanding neuropsychiatric SLE (NPSLE), one of the poorest understood manifestations of SLE for which no biomarkers are available. We studied the levels of complement inhibitors in SLE in relation to disease activity and as possible biomarkers to identify NPSLE. Serum levels of complement inhibitors C1‐inhibitor (C1‐INH), C4b‐binding protein (C4BP), Factor I, and Factor H were measured in 345 SLE patients (including 102 with NPSLE) and 108 healthy controls. Compared with controls, SLE patients had higher C1‐INH and C4BP but lower Factor I and H levels. All inhibitors positively correlated with total C3 and C4 levels. While correlating with the SLE Disease Activity Index (SLEDAI), no distinction in inhibitor levels was found between SLE and NPSLE patients. Over time, C1‐INH and Factor H levels normalized, but no significant changes were observed for C4BP and Factor I. In SLE the levels of circulating complement inhibitors are inversely correlated to complement consumption but do not serve as biomarkers for NPSLE.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lupus Erythematosus, SystemicComplement C1 Inhibitor ProteinBiomarkersComplement Factor HComplement C4b-Binding ProteinHumansFemaleAdultMaleMiddle AgedComplement ActivationComplement Factor ILupus Vasculitis, Central Nervous SystemComplement C4Complement C3Aged

Stichwörter der Autor:innen

AutoimmunityComplement system

Substanzen

Complement C1 Inhibitor ProteinBiomarkersComplement Factor HComplement C4b-Binding ProteinComplement Factor IComplement C4Complement C3C4BPA protein, human

Autor:innen und Institutionen

  • Department of Immunology, Leiden University Medical Center, Leiden, the Netherlands.
  • Department of Rheumatology, Leiden University Medical Center, Leiden, the Netherlands.
  • Sanquin Diagnostic Services, Amsterdam, the Netherlands.
  • Department of Internal Medicine section Nephrology, Center of Expertise for Lupus-, Vasculitis and Complement-mediated Systemic Autoimmune Diseases, Leiden University Medical Center, Leiden, the Netherlands.
  • Department of Rheumatology, Haaglanden Medical Center, The Hague, the Netherlands.

ORCID-Profile: Stef van der Meulen, Rory C Monahan, Kyra A Gelderman, Cees van Kooten, Y K Onno Teng, Tom W J Huizinga, Gerda M Steup-Beekman, Leendert A Trouw

Förderung

  • European Research Council

Zitieren

APA

van der Meulen, S., Monahan, R. C., Gelderman, K. A., van Kooten, C., Teng, Y. K. O., Huizinga, T. W. J., Steup-Beekman, G. M., & Trouw, L. A. (2024). Circulating levels of endogenous complement inhibitors correlate inversely with complement consumption in systemic lupus erythematosus. European Journal of Immunology, 54(11). https://doi.org/10.1002/eji.202450998

Vancouver

van der Meulen S, Monahan RC, Gelderman KA, van Kooten C, Teng YKO, Huizinga TWJ, et al. Circulating levels of endogenous complement inhibitors correlate inversely with complement consumption in systemic lupus erythematosus. European Journal of Immunology. 2024;54(11). doi:10.1002/eji.202450998

BibTeX
@article{vanderMeulen2024,
  author = {van der Meulen, Stef and Monahan, Rory C and Gelderman, Kyra A and van Kooten, Cees and Teng, Y K Onno and Huizinga, Tom W J and Steup-Beekman, Gerda M and Trouw, Leendert A},
  title = {Circulating levels of endogenous complement inhibitors correlate inversely with complement consumption in systemic lupus erythematosus},
  journal = {European Journal of Immunology},
  year = {2024},
  volume = {54},
  number = {11},
  doi = {10.1002/eji.202450998}
}
Kostenlos starten →